120 related articles for article (PubMed ID: 7065839)
1. Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response.
van Kammen DP; Docherty JP; Marder SR; Schulz SC; Dalton L; Bunney WE
Arch Gen Psychiatry; 1982 Mar; 39(3):261-6. PubMed ID: 7065839
[TBL] [Abstract][Full Text] [Related]
2. Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia.
van Kammen DP; Docherty JP; Marder SR; Rayner JN; Bunney WE
Arch Gen Psychiatry; 1982 Mar; 39(3):275-81. PubMed ID: 6802100
[TBL] [Abstract][Full Text] [Related]
3. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
van Kammen DP; Docherty JP; Bunney WE
Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
[TBL] [Abstract][Full Text] [Related]
4. Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients.
van Kammen DP; Docherty JP; Marder SR; Schulz SC; Bunney WE
Arch Gen Psychiatry; 1980 Mar; 37(3):287-90. PubMed ID: 6102456
[TBL] [Abstract][Full Text] [Related]
5. Dextro-amphetamine diminishes negative symptoms in schizophrenia.
van Kammen DP; Boronow JJ
Int Clin Psychopharmacol; 1988 Apr; 3(2):111-21. PubMed ID: 3294284
[TBL] [Abstract][Full Text] [Related]
6. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.
Silverstone T; Cookson J; Ball R; Chin CN; Jacobs D; Lader S; Gould S
J Psychiatr Res; 1984; 18(3):255-68. PubMed ID: 6387105
[TBL] [Abstract][Full Text] [Related]
7. Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?
van Kammen DP; Hommer DW; Malas KL
Neuropsychobiology; 1987; 18(3):113-7. PubMed ID: 3453426
[TBL] [Abstract][Full Text] [Related]
8. d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia.
van Kammen DP; Bunney WE; Docherty JP; Marder SR; Ebert MH; Rosenblatt JE; Rayner JN
Am J Psychiatry; 1982 Aug; 139(8):991-7. PubMed ID: 7091448
[TBL] [Abstract][Full Text] [Related]
9. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pimozide and chlorpromazine in acute schizophrenia.
Pecknold JC; McClure DJ; Allan T; Wrzesinski L
Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
[TBL] [Abstract][Full Text] [Related]
11. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
[TBL] [Abstract][Full Text] [Related]
12. [Dose-effect relations. Doubleblind study on two different doses of pimozide (author's transl)].
Fleischhauer J
Arzneimittelforschung; 1978; 28(9):1491-2. PubMed ID: 582541
[TBL] [Abstract][Full Text] [Related]
13. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study.
Haas S; Beckmann H
Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.
Goldberg TE; Bigelow LB; Weinberger DR; Daniel DG; Kleinman JE
Am J Psychiatry; 1991 Jan; 148(1):78-84. PubMed ID: 1984711
[TBL] [Abstract][Full Text] [Related]
15. Pimozide in the treatment of newly admitted schizophrenic patients.
Chouinard G; Annable L
Psychopharmacology (Berl); 1982; 76(1):13-9. PubMed ID: 6805002
[TBL] [Abstract][Full Text] [Related]
16. Interactions of amphetamine, pimozide, and lithium on plasma norepineophrine and dopamine-beta-hydroxylase in schizophrenic patients.
Rosenblatt JE; Lake CR; van Kammen DP; Ziegler MG; Bunney WE
Psychiatry Res; 1979 Jul; 1(1):45-52. PubMed ID: 298337
[TBL] [Abstract][Full Text] [Related]
17. Pimozide for schizophrenia or related psychoses.
Mothi M; Sampson S
Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
[TBL] [Abstract][Full Text] [Related]
18. The effect of pimozide on CSF norepinephrine in schizophrenia.
Sternberg DE; van Kammen DP; Lake CR; Ballenger JC; Marder SR; Bunney WE
Am J Psychiatry; 1981 Aug; 138(8):1045-50. PubMed ID: 7258379
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin and antipsychotic responses to pimozide in schizophrenia.
Siris SG; van Kammen DP; De Fraites EG
Psychopharmacol Bull; 1978 Jan; 14(1):11-4. PubMed ID: 625528
[No Abstract] [Full Text] [Related]
20. d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment.
van Kammen DP; Docherty JP; Marder SR; Siris SG; Bunney WE
Life Sci; 1978 Oct; 23(14):1487-92. PubMed ID: 362103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
